Locus Fermentation Solutions, a U.S.-based biotechnology company producing performance-enhancing bio-based additives, announced the close of an oversubscribed $20 million investment in a convertible note round at an equity valuation of $100M led by Hudson Bay Capital, with the opportunity to up-size the round. The capital will be used to expand the company's domestic biomanufacturing capacity, accelerate commercial activities and product development across four strategic sectors: oil & gas, mining, agriculture, and industrial/CPG formulations. This latest round brings total funding this year to over $40 million in growth capital and includes participation from company leadership.